flanders.bio is the cluster organisation empowering a life sciences driven network economy

flanders.bio is a dynamic, member driven organisation with currently more than 350 members from Belgium and abroad. We help our members to create value by organising Networking and Training Activities, supporting Internationalisation, providing Services and building Expertise. flanders.bio and its members want to be the proud advocates of a reputable global-impact ecosystem in life sciences.

News from flanders.bio and its members

Versterk ons team! flanders.bio zoekt een communicatiemedewerker

Ter ondersteuning van onze activiteiten en ter versterking van ons team zijn wij op zoek naar een COMMUNICATIEMEDEWERKER (m/v).

People | 14 August 17 Read more

Ablynx will announce its 2017 half year results with webcast on 24 august 2017

Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] will report its 2017 half year financial results and year-to-date business update on Thursday 24 August 2017 at 7.00 am CET.

Finance | 17 August 17 Read more

argenx to host conference call & webcast to report second quarter business update and half year 2017 financial results

argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer, today announced it will host a conference call and audio webcast on Thursday, August 24, 2017 at 3:00 p.m. CEST (9:00 a.m. EDT) to discuss financial results for the first half of 2017 and to provide a second quarter business update.

Finance | 17 August 17 Read more

Navigation and spatial memory: new brain region identified to be involved

Navigation in mammals including humans and rodents depends on specialized neural networks that encode the animal’s location and trajectory in the environment, serving essentially as a GPS, findings that led to the 2014 Nobel Prize in Medicine. Failure of these networks to function properly, as seen in Alzheimer’s disease and other neurological conditions, results in severe disorientation and memory deficits. Researchers at NERF (VIB-imec-KU Leuven) have now uncovered striking neural activity patterns in a brain area called the retrosplenial cortex that may assist with spatial memory and navigation.

Research | 16 August 17 Read more

New ThromboGenics' Ocriplasmin Clinical and Health Economic Data Presented at ASRS 2017 Annual Scientific Meeting in Boston

ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel treatments for diabetic eye disease, announced today that further ocriplasmin clinical and health economic data was presented at the 35th Annual Scientific Meeting of the American Society of Retina Specialists (ASRS). The meeting was held from August 11th through August 15th, 2017 in Boston, MA.

Research | 16 August 17 Read more

flanders.bio events, trainings & international missions

Strategic Partners